NCT04464226 Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04463992 Lay Health Worker Expanded Intervention in Community Oncology Practices Status COMPLETED Phase NA
NCT04462302 An Internet-based Program to Help Cancer Survivors Manage Pain Status ACTIVE_NOT_RECRUITING Phase NA
NCT04459234 Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC Status COMPLETED Phase N/A
NCT04457713 Off-label Use of Anti-cancer Drugs in Norway -a Prospective Cohort Study Status RECRUITING Phase N/A
NCT04455698 Engaging and Activating Cancer Survivors in Genetic Services Study Status COMPLETED Phase NA
NCT04452305 Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting Status RECRUITING Phase NA
NCT04449783 Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery Status UNKNOWN Phase N/A
NCT04448678 Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients Status COMPLETED Phase NA
NCT04448041 CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries Status COMPLETED Phase N/A
NCT04447235 Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection Status TERMINATED Phase PHASE2
NCT04445870 Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study Status COMPLETED Phase N/A
NCT04443088 An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT04442425 Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain Status COMPLETED Phase N/A
NCT04442048 Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure Status COMPLETED Phase PHASE3